Rethinking ovarian cancer: recommendations for improving outcomes.

Détails

ID Serval
serval:BIB_A9507A5CA56B
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Rethinking ovarian cancer: recommendations for improving outcomes.
Périodique
Nature Reviews. Cancer
Auteur⸱e⸱s
Vaughan S., Coward J.I., Bast R.C., Berchuck A., Berek J.S., Brenton J.D., Coukos G., Crum C.C., Drapkin R., Etemadmoghadam D., Friedlander M., Gabra H., Kaye S.B., Lord C.J., Lengyel E., Levine D.A., McNeish I.A., Menon U., Mills G.B., Nephew K.P., Oza A.M., Sood A.K., Stronach E.A., Walczak H., Bowtell D.D., Balkwill F.R.
ISSN
1474-1768 (Electronic)
ISSN-L
1474-175X
Statut éditorial
Publié
Date de publication
2011
Volume
11
Numéro
10
Pages
719-725
Langue
anglais
Notes
Publication types: Consensus Development Conference ; Guideline ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.Publication Status: epublish
Résumé
There have been major advances in our understanding of the cellular and molecular biology of the human malignancies that are collectively referred to as ovarian cancer. At a recent Helene Harris Memorial Trust meeting, an international group of researchers considered actions that should be taken to improve the outcome for women with ovarian cancer. Nine major recommendations are outlined in this Opinion article.
Mots-clé
Animals, Antineoplastic Agents/therapeutic use, Clinical Trials as Topic, Female, Health Planning Guidelines, Humans, Ovarian Neoplasms/drug therapy, Ovarian Neoplasms/genetics, Practice Guidelines as Topic, Treatment Outcome
Pubmed
Web of science
Création de la notice
14/10/2014 12:43
Dernière modification de la notice
20/08/2019 16:13
Données d'usage